Other
Infectious Disease Institute, Kampala, Uganda
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
80%
4 trials in Phase 3/4
Results Transparency
40%
2 of 5 completed trials have results
Key Signals
2 with results
Enrollment Performance
Analytics
Phase 3
2(40.0%)
Phase 4
2(40.0%)
Phase 2
1(20.0%)
5Total
Phase 3(2)
Phase 4(2)
Phase 2(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT03725618Phase 4Completed
Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old
Role: collaborator
NCT03282799Phase 2Completed
Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women
Role: collaborator
NCT04166474Phase 4Completed
Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin
Role: collaborator
NCT01802385Phase 3Completed
Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis
Role: collaborator
NCT01228578Phase 3Completed
Multi-vitamins, HAART and HIV/AIDS in Uganda
Role: collaborator
All 5 trials loaded